Preventive double mastectomies raise questions over who should be tested for the BRCA1 gene mutation, and why

May 14, 2013
Angelina Jolie's decision to have a preventive double mastectomy because she has the BRCA1 gene mutation has raised concern over who else should be tested for the gene, and why. Dr. Alison Conlin and Dr. Heidi Nelson of the Providence Cancer Center explain gene mutation and breast health in an article for the Oregonian. 

Read Dr. Conlin and Dr. Nelson's thoughts in the Oregonian >>